Dimensional Fund Advisors
GBT

Dimensional Fund Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Dimensional Fund Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-88,277
Closed -$6.01M – 3567
2022
Q3 		$6.01M Sell
88,277
-1,137
-1% -$62.7K ﹤0.01% 2360
2022
Q2 		$2.86M Sell
89,414
-441,279
-83% -$12.9M ﹤0.01% 2633
2022
Q1 		$18.4M Buy
530,693
+111,130
+26% +$3.32M 0.01% 2005
2021
Q4 		$12.3M Buy
419,563
+81,056
+24% +$2.51M ﹤0.01% 2223
2021
Q3 		$8.63M Sell
338,507
-62,145
-16% -$1.83M ﹤0.01% 2393
2021
Q2 		$14M Buy
400,652
+23,146
+6% +$904K ﹤0.01% 2206
2021
Q1 		$15.4M Sell
377,506
-32,612
-8% -$1.5M 0.01% 2133
2020
Q4 		$17.8M Sell
410,118
-45,319
-10% -$2.23M 0.01% 2039
2020
Q3 		$25.1M Sell
455,437
-9,491
-2% -$603K 0.01% 1731
2020
Q2 		$29.4M Sell
464,928
-17,935
-4% -$1.23M 0.01% 1619
2020
Q1 		$24.7M Sell
482,863
-7,629
-2% -$511K 0.01% 1601
2019
Q4 		$39M Buy
490,492
+41,076
+9% +$2.43M 0.01% 1648
2019
Q3 		$21.8M Buy
449,416
+8,333
+2% +$434K 0.01% 1956
2019
Q2 		$23.2M Sell
441,083
-40,786
-8% -$2.34M 0.01% 1967
2019
Q1 		$25.5M Sell
481,869
-10,551
-2% -$518K 0.01% 1921
2018
Q4 		$20.2M Buy
492,420
+409,934
+497% +$15.4M 0.01% 1965
2018
Q3 		$3.13M Buy
+82,486
New +$3.65M ﹤0.01% 2810

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dimensional Fund Advisors's GBT Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 88,277 shares — an estimated $6.01M sold.

Dimensional Fund Advisors first reported a position in GBT in Q3 2018 and held it in 17 quarters. The position peaked at $39M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 88,277 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6.01M.
  • Dimensional Fund Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and held it in 17 quarters.
  • Dimensional Fund Advisors's Global Blood Therapeutics, Inc. position peaked at $39M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.